JP2016504381A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016504381A5 JP2016504381A5 JP2015551671A JP2015551671A JP2016504381A5 JP 2016504381 A5 JP2016504381 A5 JP 2016504381A5 JP 2015551671 A JP2015551671 A JP 2015551671A JP 2015551671 A JP2015551671 A JP 2015551671A JP 2016504381 A5 JP2016504381 A5 JP 2016504381A5
- Authority
- JP
- Japan
- Prior art keywords
- barrier
- forming composition
- disease
- streptococcus
- symptoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 38
- 201000010099 disease Diseases 0.000 claims 18
- 244000005700 microbiome Species 0.000 claims 16
- 206010046306 Upper respiratory tract infection Diseases 0.000 claims 6
- 241000124008 Mammalia Species 0.000 claims 5
- 241000606125 Bacteroides Species 0.000 claims 4
- KWGRBVOPPLSCSI-WPRPVWTQSA-N Ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 claims 4
- 206010024971 Lower respiratory tract infection Diseases 0.000 claims 4
- 241000191967 Staphylococcus aureus Species 0.000 claims 4
- 229940076185 Staphylococcus aureus Drugs 0.000 claims 4
- 241000194017 Streptococcus Species 0.000 claims 4
- 239000004599 antimicrobial Substances 0.000 claims 4
- 239000011248 coating agent Substances 0.000 claims 4
- 238000000576 coating method Methods 0.000 claims 4
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims 3
- 241000709661 Enterovirus Species 0.000 claims 3
- 241000605986 Fusobacterium nucleatum Species 0.000 claims 3
- 239000003242 anti bacterial agent Substances 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 229940079593 drugs Drugs 0.000 claims 3
- 210000004877 mucosa Anatomy 0.000 claims 3
- 241000712461 unidentified influenza virus Species 0.000 claims 3
- 239000000080 wetting agent Substances 0.000 claims 3
- VUKAUDKDFVSVFT-UHFFFAOYSA-N 2-[6-[4,5-bis(2-hydroxypropoxy)-2-(2-hydroxypropoxymethyl)-6-methoxyoxan-3-yl]oxy-4,5-dimethoxy-2-(methoxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)-5-methoxyoxane-3,4-diol Chemical compound COC1C(OC)C(OC2C(C(O)C(OC)C(CO)O2)O)C(COC)OC1OC1C(COCC(C)O)OC(OC)C(OCC(C)O)C1OCC(C)O VUKAUDKDFVSVFT-UHFFFAOYSA-N 0.000 claims 2
- SUVMJBTUFCVSAD-JTQLQIEISA-N 4-Methylsulfinylbutyl isothiocyanate Natural products C[S@](=O)CCCCN=C=S SUVMJBTUFCVSAD-JTQLQIEISA-N 0.000 claims 2
- 229960004308 ACETYLCYSTEINE Drugs 0.000 claims 2
- 241000588626 Acinetobacter baumannii Species 0.000 claims 2
- OROGSEYTTFOCAN-DNJOTXNNSA-N Codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 claims 2
- 206010011224 Cough Diseases 0.000 claims 2
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 claims 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N Indometacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 claims 2
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 claims 2
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 claims 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N Methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 claims 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M NaHCO3 Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims 2
- 206010068319 Oropharyngeal pain Diseases 0.000 claims 2
- 208000002193 Pain Diseases 0.000 claims 2
- 206010035664 Pneumonia Diseases 0.000 claims 2
- 241000605862 Porphyromonas gingivalis Species 0.000 claims 2
- 241000605861 Prevotella Species 0.000 claims 2
- 206010037660 Pyrexia Diseases 0.000 claims 2
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Resveratrol Natural products C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims 2
- 206010039101 Rhinorrhoea Diseases 0.000 claims 2
- 241000580858 Simian-Human immunodeficiency virus Species 0.000 claims 2
- 241000194026 Streptococcus gordonii Species 0.000 claims 2
- 241001134658 Streptococcus mitis Species 0.000 claims 2
- 241000194019 Streptococcus mutans Species 0.000 claims 2
- 229940031008 Streptococcus mutans Drugs 0.000 claims 2
- 241000194025 Streptococcus oralis Species 0.000 claims 2
- 241000193998 Streptococcus pneumoniae Species 0.000 claims 2
- 229940031000 Streptococcus pneumoniae Drugs 0.000 claims 2
- 241000193996 Streptococcus pyogenes Species 0.000 claims 2
- 229940076156 Streptococcus pyogenes Drugs 0.000 claims 2
- 241000700605 Viruses Species 0.000 claims 2
- 230000000844 anti-bacterial Effects 0.000 claims 2
- 230000003385 bacteriostatic Effects 0.000 claims 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L calcium carbonate Chemical group [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims 2
- -1 cyclidine Chemical compound 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 229960002179 ephedrine Drugs 0.000 claims 2
- 229920000591 gum Polymers 0.000 claims 2
- 229960001680 ibuprofen Drugs 0.000 claims 2
- 229960003085 meticillin Drugs 0.000 claims 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- 238000002560 therapeutic procedure Methods 0.000 claims 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N α-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2R,3R,4S,5R,6S)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2S,3R,4S,5R,6R)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2R,3R,4S,5R,6R)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 claims 1
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1H-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 claims 1
- CNIIGCLFLJGOGP-UHFFFAOYSA-N 2-(naphthalen-1-ylmethyl)-4,5-dihydro-1H-imidazole Chemical compound C=1C=CC2=CC=CC=C2C=1CC1=NCCN1 CNIIGCLFLJGOGP-UHFFFAOYSA-N 0.000 claims 1
- 229940022659 Acetaminophen Drugs 0.000 claims 1
- JBDGDEWWOUBZPM-XYPYZODXSA-N Ambroxol Chemical compound NC1=C(Br)C=C(Br)C=C1CN[C@@H]1CC[C@@H](O)CC1 JBDGDEWWOUBZPM-XYPYZODXSA-N 0.000 claims 1
- 229960005174 Ambroxol Drugs 0.000 claims 1
- ATALOFNDEOCMKK-OITMNORJSA-N Aprepitant Chemical compound O([C@@H]([C@@H]1C=2C=CC(F)=CC=2)O[C@H](C)C=2C=C(C=C(C=2)C(F)(F)F)C(F)(F)F)CCN1CC1=NNC(=O)N1 ATALOFNDEOCMKK-OITMNORJSA-N 0.000 claims 1
- 241000228212 Aspergillus Species 0.000 claims 1
- 241000894006 Bacteria Species 0.000 claims 1
- 206010004054 Bacterial upper respiratory tract infection Diseases 0.000 claims 1
- 229940052491 Bordetella pertussis Drugs 0.000 claims 1
- 241000588832 Bordetella pertussis Species 0.000 claims 1
- OJGDCBLYJGHCIH-UHFFFAOYSA-N Bromhexine Chemical compound C1CCCCC1N(C)CC1=CC(Br)=CC(Br)=C1N OJGDCBLYJGHCIH-UHFFFAOYSA-N 0.000 claims 1
- 241001453380 Burkholderia Species 0.000 claims 1
- 229960003563 Calcium Carbonate Drugs 0.000 claims 1
- 241000222122 Candida albicans Species 0.000 claims 1
- 229940095731 Candida albicans Drugs 0.000 claims 1
- 241000222178 Candida tropicalis Species 0.000 claims 1
- 241000218236 Cannabis Species 0.000 claims 1
- YKPUWZUDDOIDPM-SOFGYWHQSA-N Capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 claims 1
- 210000000170 Cell Membrane Anatomy 0.000 claims 1
- 241000222290 Cladosporium Species 0.000 claims 1
- 241000193163 Clostridioides difficile Species 0.000 claims 1
- KXGVEGMKQFWNSR-LLQZFEROSA-N Deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 claims 1
- UREBDLICKHMUKA-CXSFZGCWSA-N Dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 claims 1
- 229960003957 Dexamethasone Drugs 0.000 claims 1
- 229960001985 Dextromethorphan Drugs 0.000 claims 1
- MKXZASYAUGDDCJ-SZMVWBNQSA-N Dextromethorphan Chemical compound C1CCC[C@H]2[C@@]3([H])N(C)CC[C@]21C1=CC(OC)=CC=C1C3 MKXZASYAUGDDCJ-SZMVWBNQSA-N 0.000 claims 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N Diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 claims 1
- MBMBGCFOFBJSGT-KUBAVDMBSA-N Docosahexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims 1
- CGHRJBLSXVCYQF-YXSUXZIUSA-N Dolasetron Chemical compound C1=CC=C[C]2C(C(O[C@@H]3C[C@@H]4C[C@@H]5C[C@@H](N4CC5=O)C3)=O)=CN=C21 CGHRJBLSXVCYQF-YXSUXZIUSA-N 0.000 claims 1
- CYQFCXCEBYINGO-DLBZAZTESA-N Dronabinol Natural products C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@H]21 CYQFCXCEBYINGO-DLBZAZTESA-N 0.000 claims 1
- 241000196324 Embryophyta Species 0.000 claims 1
- 241000305071 Enterobacterales Species 0.000 claims 1
- 241000588724 Escherichia coli Species 0.000 claims 1
- 229960005293 Etodolac Drugs 0.000 claims 1
- XFBVBWWRPKNWHW-UHFFFAOYSA-N Etodolac Chemical compound C1COC(CC)(CC(O)=O)C2=N[C]3C(CC)=CC=CC3=C21 XFBVBWWRPKNWHW-UHFFFAOYSA-N 0.000 claims 1
- 206010016256 Fatigue Diseases 0.000 claims 1
- ZWJINEZUASEZBH-UHFFFAOYSA-N Fenamic acid Chemical class OC(=O)C1=CC=CC=C1NC1=CC=CC=C1 ZWJINEZUASEZBH-UHFFFAOYSA-N 0.000 claims 1
- 241000233866 Fungi Species 0.000 claims 1
- 241000605909 Fusobacterium Species 0.000 claims 1
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 claims 1
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims 1
- 229920002907 Guar gum Polymers 0.000 claims 1
- 206010019233 Headache Diseases 0.000 claims 1
- 241000709721 Hepatovirus A Species 0.000 claims 1
- 208000009889 Herpes Simplex Diseases 0.000 claims 1
- 208000006572 Human Influenza Diseases 0.000 claims 1
- 241000709701 Human poliovirus 1 Species 0.000 claims 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 claims 1
- DOUYETYNHWVLEO-UHFFFAOYSA-N Imiquimod Chemical compound C1=CC=CC2=C3N(CC(C)C)C=NC3=C(N)N=C21 DOUYETYNHWVLEO-UHFFFAOYSA-N 0.000 claims 1
- 229960000905 Indomethacin Drugs 0.000 claims 1
- 206010022000 Influenza Diseases 0.000 claims 1
- 229940045505 Klebsiella pneumoniae Drugs 0.000 claims 1
- 241000588747 Klebsiella pneumoniae Species 0.000 claims 1
- DLNKOYKMWOXYQA-APPZFPTMSA-N L-Norpseudoephedrine Chemical compound C[C@@H](N)[C@H](O)C1=CC=CC=C1 DLNKOYKMWOXYQA-APPZFPTMSA-N 0.000 claims 1
- MYWUZJCMWCOHBA-SECBINFHSA-N Levomethamphetamine Chemical compound CN[C@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-SECBINFHSA-N 0.000 claims 1
- 229960004488 Linolenic Acid Drugs 0.000 claims 1
- 229960002983 Loperamide Hydrochloride Drugs 0.000 claims 1
- DIWRORZWFLOCLC-UHFFFAOYSA-N Lorazepam Chemical compound C12=CC(Cl)=CC=C2NC(=O)C(O)N=C1C1=CC=CC=C1Cl DIWRORZWFLOCLC-UHFFFAOYSA-N 0.000 claims 1
- 210000002540 Macrophages Anatomy 0.000 claims 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L Magnesium hydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 claims 1
- 210000004379 Membranes Anatomy 0.000 claims 1
- DDLIGBOFAVUZHB-UHFFFAOYSA-N Midazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NC=C2CN=C1C1=CC=CC=C1F DDLIGBOFAVUZHB-UHFFFAOYSA-N 0.000 claims 1
- 229960003793 Midazolam Drugs 0.000 claims 1
- 210000002200 Mouth Mucosa Anatomy 0.000 claims 1
- 210000003097 Mucus Anatomy 0.000 claims 1
- CMWTZPSULFXXJA-VIFPVBQESA-N Naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 claims 1
- 210000002850 Nasal Mucosa Anatomy 0.000 claims 1
- 206010028813 Nausea Diseases 0.000 claims 1
- 102000002002 Neurokinin-1 Receptors Human genes 0.000 claims 1
- 108010040718 Neurokinin-1 Receptors Proteins 0.000 claims 1
- AKNNEGZIBPJZJG-MSOLQXFVSA-N Noscapine Chemical compound CN1CCC2=CC=3OCOC=3C(OC)=C2[C@@H]1[C@@H]1C2=CC=C(OC)C(OC)=C2C(=O)O1 AKNNEGZIBPJZJG-MSOLQXFVSA-N 0.000 claims 1
- 229960004708 Noscapine Drugs 0.000 claims 1
- 210000001331 Nose Anatomy 0.000 claims 1
- 229940005483 OPIOID ANALGESICS Drugs 0.000 claims 1
- KVWDHTXUZHCGIO-UHFFFAOYSA-N Olanzapine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2NC2=C1C=C(C)S2 KVWDHTXUZHCGIO-UHFFFAOYSA-N 0.000 claims 1
- WYWIFABBXFUGLM-UHFFFAOYSA-N Oxymetazoline Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C)=C1CC1=NCCN1 WYWIFABBXFUGLM-UHFFFAOYSA-N 0.000 claims 1
- 240000004678 Panax pseudoginseng Species 0.000 claims 1
- 235000003140 Panax quinquefolius Nutrition 0.000 claims 1
- 210000003695 Paranasal Sinuses Anatomy 0.000 claims 1
- 241000228143 Penicillium Species 0.000 claims 1
- 229960001802 Phenylephrine Drugs 0.000 claims 1
- SONNWYBIRXJNDC-VIFPVBQESA-N Phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 claims 1
- 229960000395 Phenylpropanolamine Drugs 0.000 claims 1
- 244000090599 Plantago psyllium Species 0.000 claims 1
- 235000010451 Plantago psyllium Nutrition 0.000 claims 1
- 241000605894 Porphyromonas Species 0.000 claims 1
- JCRIVQIOJSSCQD-UHFFFAOYSA-N Propylhexedrine Chemical compound CNC(C)CC1CCCCC1 JCRIVQIOJSSCQD-UHFFFAOYSA-N 0.000 claims 1
- 229960000786 Propylhexedrine Drugs 0.000 claims 1
- BXNMTOQRYBFHNZ-UHFFFAOYSA-N Resiquimod Chemical compound C1=CC=CC2=C(N(C(COCC)=N3)CC(C)(C)O)C3=C(N)N=C21 BXNMTOQRYBFHNZ-UHFFFAOYSA-N 0.000 claims 1
- 229950010550 Resiquimod Drugs 0.000 claims 1
- 206010057190 Respiratory tract infection Diseases 0.000 claims 1
- 206010039083 Rhinitis Diseases 0.000 claims 1
- 206010061494 Rhinovirus infection Diseases 0.000 claims 1
- 241000702670 Rotavirus Species 0.000 claims 1
- STECJAGHUSJQJN-FWXGHANASA-N Scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 claims 1
- 241000700584 Simplexvirus Species 0.000 claims 1
- 206010041232 Sneezing Diseases 0.000 claims 1
- 241000549372 Solobacterium Species 0.000 claims 1
- 206010041925 Staphylococcal infection Diseases 0.000 claims 1
- 206010061372 Streptococcal infection Diseases 0.000 claims 1
- 229940033346 Synephrine Drugs 0.000 claims 1
- 229940033529 Tetrahydrocannabinol Drugs 0.000 claims 1
- BYJAVTDNIXVSPW-UHFFFAOYSA-N Tetrahydrozoline Chemical compound N1CCN=C1C1C2=CC=CC=C2CCC1 BYJAVTDNIXVSPW-UHFFFAOYSA-N 0.000 claims 1
- 241000589892 Treponema denticola Species 0.000 claims 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Tris Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims 1
- 229960004418 Trolamine Drugs 0.000 claims 1
- 208000009470 Ventilator-Associated Pneumonia Diseases 0.000 claims 1
- 206010047482 Viral upper respiratory tract infection Diseases 0.000 claims 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Vitamin C Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 1
- 206010047700 Vomiting Diseases 0.000 claims 1
- 241000607734 Yersinia <bacteria> Species 0.000 claims 1
- 241000607447 Yersinia enterocolitica Species 0.000 claims 1
- 229940098232 Yersinia enterocolitica Drugs 0.000 claims 1
- WUFQXLSMHUWKAL-UHFFFAOYSA-L [Bi+2].OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O Chemical compound [Bi+2].OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O WUFQXLSMHUWKAL-UHFFFAOYSA-L 0.000 claims 1
- 241000222126 [Candida] glabrata Species 0.000 claims 1
- 239000002250 absorbent Substances 0.000 claims 1
- 230000002745 absorbent Effects 0.000 claims 1
- 150000001242 acetic acid derivatives Chemical class 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims 1
- 229910052782 aluminium Inorganic materials 0.000 claims 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminum Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims 1
- 150000003868 ammonium compounds Chemical group 0.000 claims 1
- 230000000954 anitussive Effects 0.000 claims 1
- 235000010208 anthocyanin Nutrition 0.000 claims 1
- 239000004410 anthocyanin Substances 0.000 claims 1
- 150000004636 anthocyanins Chemical class 0.000 claims 1
- 229930002877 anthocyanins Natural products 0.000 claims 1
- 230000000181 anti-adherence Effects 0.000 claims 1
- 230000001078 anti-cholinergic Effects 0.000 claims 1
- 229940111131 antiinflammatory and antirheumatic products Propionic acid derivatives Drugs 0.000 claims 1
- 239000003434 antitussive agent Substances 0.000 claims 1
- 229960001372 aprepitant Drugs 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 229960005070 ascorbic acid Drugs 0.000 claims 1
- 235000010323 ascorbic acid Nutrition 0.000 claims 1
- 239000011668 ascorbic acid Substances 0.000 claims 1
- 229960003870 bromhexine Drugs 0.000 claims 1
- 229910000019 calcium carbonate Inorganic materials 0.000 claims 1
- 229930003827 cannabinoid Natural products 0.000 claims 1
- 230000002149 cannabinoid Effects 0.000 claims 1
- 239000003557 cannabinoid Substances 0.000 claims 1
- 229960002504 capsaicin Drugs 0.000 claims 1
- 229930003833 capsaicin Natural products 0.000 claims 1
- 235000017663 capsaicin Nutrition 0.000 claims 1
- 150000001746 carotenes Chemical class 0.000 claims 1
- 235000005473 carotenes Nutrition 0.000 claims 1
- 230000030833 cell death Effects 0.000 claims 1
- 229960004126 codeine Drugs 0.000 claims 1
- 238000011109 contamination Methods 0.000 claims 1
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 claims 1
- 229960003964 deoxycholic acid Drugs 0.000 claims 1
- 229960001259 diclofenac Drugs 0.000 claims 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 claims 1
- 229960000520 diphenhydramine Drugs 0.000 claims 1
- 201000009910 diseases by infectious agent Diseases 0.000 claims 1
- 238000004090 dissolution Methods 0.000 claims 1
- 229960003413 dolasetron Drugs 0.000 claims 1
- 239000003210 dopamine receptor blocking agent Substances 0.000 claims 1
- 229960004242 dronabinol Drugs 0.000 claims 1
- 230000003419 expectorant Effects 0.000 claims 1
- 239000003172 expectorant agent Substances 0.000 claims 1
- 239000000835 fiber Substances 0.000 claims 1
- 235000021285 flavonoid Nutrition 0.000 claims 1
- 150000002215 flavonoids Chemical class 0.000 claims 1
- 229930003935 flavonoids Natural products 0.000 claims 1
- 239000010647 garlic oil Substances 0.000 claims 1
- 235000005035 ginseng Nutrition 0.000 claims 1
- 235000008434 ginseng Nutrition 0.000 claims 1
- 239000000665 guar gum Substances 0.000 claims 1
- 229960002154 guar gum Drugs 0.000 claims 1
- 235000010417 guar gum Nutrition 0.000 claims 1
- 231100000869 headache Toxicity 0.000 claims 1
- 239000000938 histamine H1 antagonist Substances 0.000 claims 1
- 235000012907 honey Nutrition 0.000 claims 1
- 239000010903 husk Substances 0.000 claims 1
- 229960002751 imiquimod Drugs 0.000 claims 1
- 230000003344 immunostimulant Effects 0.000 claims 1
- 239000003022 immunostimulating agent Substances 0.000 claims 1
- 235000012891 isoflavonoids Nutrition 0.000 claims 1
- 150000003816 isoflavonoids Chemical class 0.000 claims 1
- 229930013032 isoflavonoids Natural products 0.000 claims 1
- 229950007554 levmetamfetamine Drugs 0.000 claims 1
- PGYPOBZJRVSMDS-UHFFFAOYSA-N loperamide hydrochloride Chemical compound Cl.C=1C=CC=CC=1C(C=1C=CC=CC=1)(C(=O)N(C)C)CCN(CC1)CCC1(O)C1=CC=C(Cl)C=C1 PGYPOBZJRVSMDS-UHFFFAOYSA-N 0.000 claims 1
- 229960004391 lorazepam Drugs 0.000 claims 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 1
- 239000011777 magnesium Substances 0.000 claims 1
- 229910052749 magnesium Inorganic materials 0.000 claims 1
- 239000000347 magnesium hydroxide Substances 0.000 claims 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 229920000609 methyl cellulose Polymers 0.000 claims 1
- 229960001047 methyl salicylate Drugs 0.000 claims 1
- 239000001923 methylcellulose Substances 0.000 claims 1
- 239000007908 nanoemulsion Substances 0.000 claims 1
- 229960005016 naphazoline Drugs 0.000 claims 1
- 229960002009 naproxen Drugs 0.000 claims 1
- 229930014621 narcotine Natural products 0.000 claims 1
- 230000003472 neutralizing Effects 0.000 claims 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims 1
- 229960005017 olanzapine Drugs 0.000 claims 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims 1
- 230000003364 opioid Effects 0.000 claims 1
- 229960003684 oxedrine Drugs 0.000 claims 1
- 229960001528 oxymetazoline Drugs 0.000 claims 1
- RZVAJINKPMORJF-UHFFFAOYSA-N p-acetaminophenol Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims 1
- 229960005489 paracetamol Drugs 0.000 claims 1
- 150000008442 polyphenolic compounds Chemical class 0.000 claims 1
- 235000013824 polyphenols Nutrition 0.000 claims 1
- 150000005599 propionic acid derivatives Chemical class 0.000 claims 1
- 239000002464 receptor antagonist Substances 0.000 claims 1
- 235000021283 resveratrol Nutrition 0.000 claims 1
- 229940016667 resveratrol Drugs 0.000 claims 1
- WVYADZUPLLSGPU-UHFFFAOYSA-N salsalate Chemical compound OC(=O)C1=CC=CC=C1OC(=O)C1=CC=CC=C1O WVYADZUPLLSGPU-UHFFFAOYSA-N 0.000 claims 1
- 229960000953 salsalate Drugs 0.000 claims 1
- 229960002646 scopolamine Drugs 0.000 claims 1
- 239000003369 serotonin 5-HT3 receptor antagonist Substances 0.000 claims 1
- 231100000486 side effect Toxicity 0.000 claims 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims 1
- 235000017557 sodium bicarbonate Nutrition 0.000 claims 1
- 239000001187 sodium carbonate Substances 0.000 claims 1
- 229910000029 sodium carbonate Inorganic materials 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 238000005507 spraying Methods 0.000 claims 1
- 150000003431 steroids Chemical class 0.000 claims 1
- 235000015487 sulforaphane Nutrition 0.000 claims 1
- YRCWQPVGYLYSOX-UHFFFAOYSA-O synephrinium Chemical compound C[NH2+]CC(O)C1=CC=C(O)C=C1 YRCWQPVGYLYSOX-UHFFFAOYSA-O 0.000 claims 1
- 229940016284 tetrahydrozoline Drugs 0.000 claims 1
- 229960000337 tetryzoline Drugs 0.000 claims 1
- 150000003573 thiols Chemical class 0.000 claims 1
- 229940040064 ubiquinol Drugs 0.000 claims 1
- QNTNKSLOFHEFPK-UPTCCGCDSA-N ubiquinol-10 Chemical compound COC1=C(O)C(C)=C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=C1OC QNTNKSLOFHEFPK-UPTCCGCDSA-N 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361749195P | 2013-01-04 | 2013-01-04 | |
| US61/749,195 | 2013-01-04 | ||
| US201361829608P | 2013-05-31 | 2013-05-31 | |
| US61/829,608 | 2013-05-31 | ||
| US201361859960P | 2013-07-30 | 2013-07-30 | |
| US61/859,960 | 2013-07-30 | ||
| PCT/US2013/066863 WO2014107221A1 (en) | 2013-01-04 | 2013-10-25 | Method for treatment of disease caused or aggravated by microorganisms or relieving symptoms thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016504381A JP2016504381A (ja) | 2016-02-12 |
| JP2016504381A5 true JP2016504381A5 (hu) | 2016-12-08 |
| JP6901824B2 JP6901824B2 (ja) | 2021-07-14 |
Family
ID=51062409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015551671A Active JP6901824B2 (ja) | 2013-01-04 | 2013-10-25 | 微生物により引き起こされる若しくは悪化する疾患の治療方法、又はその症状の緩和方法 |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP2941255A4 (hu) |
| JP (1) | JP6901824B2 (hu) |
| WO (1) | WO2014107221A1 (hu) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014518555A (ja) | 2011-04-19 | 2014-07-31 | アームズ ファーマシューティカル エルエルシー | 有害な微生物を阻害する方法及びそのためのバリア形成組成物 |
| US10426761B2 (en) | 2011-04-19 | 2019-10-01 | Arms Pharmaceutical, Llc | Method for treatment of disease caused or aggravated by microorganisms or relieving symptoms thereof |
| US10388407B2 (en) | 2014-10-21 | 2019-08-20 | uBiome, Inc. | Method and system for characterizing a headache-related condition |
| AU2015335907A1 (en) | 2014-10-21 | 2017-04-13 | Psomagen, Inc. | Method and system for microbiome-derived diagnostics and therapeutics |
| EP3687375A4 (en) * | 2016-11-21 | 2022-01-19 | Psomagen, Inc. | METHOD AND SYSTEM FOR CHARACTERIZING A HEADACHE RELATED CONDITION |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6749869B1 (en) * | 1997-09-26 | 2004-06-15 | Ecolab | Acidic aqueous chlorite teat dip providing shelf life, sanitizing capacity and tissue protection |
| EP1686993B1 (en) * | 2003-11-07 | 2011-01-12 | Viratox, L.L.C. | Virucidal activities of a composition comprising cetylpyridinium chloride and citric acid |
| US20050191270A1 (en) * | 2004-02-27 | 2005-09-01 | Hydromer, Inc. | Anti-infectious hydrogel compositions |
| US20060019987A1 (en) * | 2004-07-23 | 2006-01-26 | Fust Charles A | Methods and compositions for inhibiting, destroying, and/or inactivating viruses |
| US20070054834A1 (en) * | 2005-04-11 | 2007-03-08 | Nanobio Corporation | Quaternary ammonium halides for treatment of infectious conditions |
| CN101868253A (zh) * | 2007-11-21 | 2010-10-20 | 宝洁公司 | 可用于咳嗽治疗的制剂、方法和试剂盒 |
| JP2014518555A (ja) * | 2011-04-19 | 2014-07-31 | アームズ ファーマシューティカル エルエルシー | 有害な微生物を阻害する方法及びそのためのバリア形成組成物 |
-
2013
- 2013-10-25 JP JP2015551671A patent/JP6901824B2/ja active Active
- 2013-10-25 WO PCT/US2013/066863 patent/WO2014107221A1/en active Application Filing
- 2013-10-25 EP EP13870018.2A patent/EP2941255A4/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016504381A5 (hu) | ||
| Thomas et al. | Therapeutic potential of tea tree oil for scabies | |
| JP2013253094A5 (hu) | ||
| CA2955982C (en) | Treatment and prevention of the common cold using povidone-iodine | |
| JP2018519361A (ja) | 口腔、咽喉及び気道の障害の治療のための配合物 | |
| Amorim et al. | New advances in the therapy of non-cystic fibrosis bronchiectasis | |
| JP6901824B2 (ja) | 微生物により引き起こされる若しくは悪化する疾患の治療方法、又はその症状の緩和方法 | |
| CO6400184A2 (es) | Formulaciones galénicas de compuestos orgánicos | |
| JP2013520448A5 (hu) | ||
| US20130216574A1 (en) | Kit providing multiple unmet therapeutic effects | |
| US20160000731A1 (en) | Sore-throat compositions and related methods | |
| Schellack et al. | Overview and management of colds and flu | |
| US20150306042A1 (en) | Body surface treatment composition and method | |
| KR102430892B1 (ko) | 비강 울혈을 치료/예방하기 위한 카르복실산 | |
| US20240165151A1 (en) | Compositions and methods for treating upper respiratory infections | |
| US9744125B2 (en) | Use of a virucidal preparation on an area of the face for prevention of transmission or contraction of viral illnesses, or to shorten the duration of, or lessen the severity of viral illnesses | |
| ECSP11010941A (es) | Composición farmacéutica para el uso en el tratamiento de infecciones de transmisión sexual | |
| US20180008598A1 (en) | Antibacterial nasal compositions and related methods | |
| CN107596166A (zh) | 一种缓解感冒头痛的中药组合物 | |
| El-Ansary et al. | Control of antibiotic resistance and superinfections as a strategy to manage COVID-19 deaths | |
| CN117083057A (zh) | 用于预防感染的组合物 | |
| US20160317467A1 (en) | Method of treating or preventing infection | |
| DOP2011000060A (es) | Composicion farmaceutica para el uso en el tratamiento de infecciones de transmision sexual | |
| CR20110106A (es) | Composición farmacéutica para el uso en el tratamiento de infecciones de transmisión sexual | |
| TH159079A (th) | องค์ประกอบต่างๆ ของยาต้านจุลชีพที่ปลดปล่อยแบบถูกควบคุมและวิธีการต่างๆ สำหรับการรักษาความผิดปกติต่างๆ ของหู |